Ankylosing spondylitis

A4.21 Effect of TNF blocking therapy on osteoclasts from ankylosing spondylitis patients
IP Perpétuo, R Raposeiro, J Caetano-Lopes, E Vieira-Sousa, R Campanilho-Marques, C Ponte, H Canhão, M Ainola, JE Fonseca

Annals of the Rheumatic Diseases Mar 2015, 74 (Suppl 1) A45; DOI: 10.1136/annrheumdis-2015-207259.103
A5.14 The profile of axial spondyloarthritis patients according to fatigue level
J Zepa, I Bulina, V Lavrentjevs, J Arajs, E Sikora, L Nikitina-Zake, A Lejnieks, D Andersone

Annals of the Rheumatic Diseases Mar 2015, 74 (Suppl 1) A52-A53; DOI: 10.1136/annrheumdis-2015-207259.120
Golimumab 3-year safety update: an analysis of pooled data from the long-term extensions of randomised, double-blind, placebo-controlled trials conducted in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis
Jonathan Kay, Roy Fleischmann, Edward Keystone, Elizabeth C Hsia, Benjamin Hsu, Michael Mack, Neil Goldstein, Jürgen Braun, Arthur Kavanaugh

Annals of the Rheumatic Diseases Mar 2015, 74 (3) 538-546; DOI: 10.1136/annrheumdis-2013-204195
Diagnostic delay in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis: results from the Danish nationwide DANBIO registry
Jan Sørensen, Merete Lund Hetland

Annals of the Rheumatic Diseases Mar 2015, 74 (3) e12; DOI: 10.1136/annrheumdis-2013-204867
Immunogenicity, adalimumab levels and clinical response in ankylosing spondylitis patients during 24 weeks of follow-up
Eva L Kneepkens, James Cheng-Chung Wei, Michael T Nurmohamed, Kai-Jieh Yeo, C Y Chen, Irene E van der Horst-Bruinsma, Desiree van der Kleij, Theo Rispens, Gertjan Wolbink, Charlotte L M Krieckaert

Annals of the Rheumatic Diseases Feb 2015, 74 (2) 396-401; DOI: 10.1136/annrheumdis-2013-204185
Quantitative syndesmophyte measurement in ankylosing spondylitis using CT: longitudinal validity and sensitivity to change over 2 years
Sovira Tan, Jianhua Yao, John A Flynn, Lawrence Yao, Michael M Ward

Annals of the Rheumatic Diseases Feb 2015, 74 (2) 437-443; DOI: 10.1136/annrheumdis-2013-203946
Tumour necrosis factor blocking agents and progression of subclinical atherosclerosis in patients with ankylosing spondylitis
Alper M van Sijl, Izhar C van Eijk, Mike J L Peters, Erik H Serné, Irene E van der Horst-Bruinsma, Yvo M Smulders, Michael T Nurmohamed

Annals of the Rheumatic Diseases Jan 2015, 74 (1) 119-123; DOI: 10.1136/annrheumdis-2013-203934
Evolution of radiographic damage in ankylosing spondylitis: a 12 year prospective follow-up of the OASIS study
Sofia Ramiro, Carmen Stolwijk, Astrid van Tubergen, Désirée van der Heijde, Maxime Dougados, Filip van den Bosch, Robert Landewé

Annals of the Rheumatic Diseases Jan 2015, 74 (1) 52-59; DOI: 10.1136/annrheumdis-2013-204055
Prevalence and incidence rates of psoriatic arthritis in central Norway: data from the Nord-Trøndelag Health Study (HUNT)
Mari Hoff, Agnete Malm Gulati, Pål Richard Romundstad, Arthur Kavanaugh, Glenn Haugeberg

Annals of the Rheumatic Diseases Jan 2015, 74 (1) 60-64; DOI: 10.1136/annrheumdis-2013-203862
Prevalence of extra-articular manifestations in patients with ankylosing spondylitis: a systematic review and meta-analysis
Carmen Stolwijk, Astrid van Tubergen, José Dionisio Castillo-Ortiz, Annelies Boonen

Annals of the Rheumatic Diseases Jan 2015, 74 (1) 65-73; DOI: 10.1136/annrheumdis-2013-203582

Main menu

Ankylosing spondylitis

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Ankylosing spondylitis

Pages